NCT03674008View on ClinicalTrials.gov

A Phase III Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or Anesthesia

PHASE3CompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

October 9, 2018

Primary Completion Date

January 9, 2019

Study Completion Date

March 10, 2019

Conditions
Sedation or Anesthesia
Interventions
DRUG

HSK3486

HSK3486 intravenous (iv) 0.4 mg/kg for induction, and 0.2 mg/kg top-ups for maintenance.

DRUG

Propofol

Propofol iv 1.5 mg/kg for induction, and 0.75 mg/kg top-ups for maintenance.

Trial Locations (1)

Unknown

West China Hospital, Sichuan University, Changde

All Listed Sponsors
lead

Sichuan Haisco Pharmaceutical Group Co., Ltd

INDUSTRY

NCT03674008 - A Phase III Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or Anesthesia | Biotech Hunter | Biotech Hunter